However, description of gender-related outcomes and analysis has remained sparse. We present our unique experience with the AngioVac system in men compared to women with tricuspid valve infective ...

However, description of its efficacy in the setting of vegetation size stratification has remained sparse. We present our unique experience with the AngioVac system in patients with tricuspid valve ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement ...

TUESDAY, Nov. 5, 2024 (HealthDay News) — For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy ...

A dedicated risk score has been proposed for patients with severe tricuspid regurgitation (TR) receiving transcatheter tricuspid valve intervention (TTVI), according to study findings published in the ...

TRAVEL II aims to evaluate the long-term safety and efficacy of LuX-Valve Plus in the application on patients with severe tricuspid regurgitation and high surgical risk. The clinical trial enrolled 96 ...

Infective endocarditis (IE) is by far the most common ... presence of micro-organisms within the lesion. Although the heart valves are most commonly affected, the disease may also occur within ...

The researchers found that the primary end point (hierarchical composite of all-cause mortality or tricuspid valve surgery, heart failure hospitalizations [HFH], and quality-of-life improvement ...

DATA presented at PCR London Valves 2024 showed that caval valve implantation (CAVI) with the TricValve system demonstrates an acceptable safety profile and significant clinical benefits in highly ...

Objective: To provide pure cohorts of paediatric and adult patients with congenital heart disease (CHD) and infective endocarditis (IE) for making future guidelines ... Right sided IE was observed in ...